Clinical Trial Update: PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot) [Phase 3]

View source ↗

Summary

Phase 3 PROTECT Pilot trial update on prophylaxis for thromboembolism in critically ill patients; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Venous Thromboembolism

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Critically Ill, Deep Venous Thrombosis | Phase 3 | Status: COMPLETED